PI-103 attenuates PI3K-AKT signaling and induces apoptosis in murineT-cell lymphoma

References

• Smith A, Crouch S, Lax S, et al. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyzes from the UK's Haematological Malignancy Research Network. Br J Cancer. 2015;112:1575–1584.
   PubMed Web of Science ®Google Scholar
• Roman E, Smith AG. Epidemiology of lymphomas. Histopathology. 2011;58:4–14.
   PubMed Web of Science ®Google Scholar
• Pathak C, Jaiswal YK, Vinayak M. Possible involvement of queuine in regulation of cell proliferation. Biofactors. 2007;29:159–173.
   PubMed Web of Science ®Google Scholar
• Das L, Vinayak M. Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer. PLoS One. 2015;10:e0124000.
   PubMed Web of Science ®Google Scholar
• Das L, Vinayak M. Long-term effect of curcumin downregulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing mice. Leuk Lymphoma. 2014;55:2627–2636.
   PubMed Web of Science ®Google Scholar
• Yeole BB. Trends in the incidence of Non-Hodgkin's lymphoma in India. Asian Pac J Cancer Prev. 2008;9:433–436.
   PubMed Web of Science ®Google Scholar
• Faes S, Dormond O. PI3K and AKT: unfaithful partners in cancer. Int J Mol Sci. 2015;16:21138–21152.
   PubMed Web of Science ®Google Scholar
• Foukas LC, Berenjeno IM, Gray A, et al. Activity of any class IA PI3K isoform can sustain cell proliferation and survival. Proc Natl Acad Sci USA. 2010;107:11381–11386.
   PubMed Web of Science ®Google Scholar
• Kloo B, Nagel D, Pfeifer M, et al. Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci USA. 2011;108:272–277.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, et al. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010;11:329–341.
   PubMed Web of Science ®Google Scholar
• Maurya AK, Vinayak M. Abstract A07: secline in the growth of murine T-cell lymphoma via modulation of PI3K signaling pathway: key role of quercetin and PI-103. Mol Cancer Ther. 2015;14:A07. doi:10.1158/1538-8514.PI3K14-A07.
   Google Scholar
• Brown KK, Toker A. The phosphoinositide 3-kinase pathway and therapy resistance in cancer. F1000Prime Rep. 2015;7:13.
   PubMedGoogle Scholar
• Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a Theme. Oncogene. 2008;27:5497–5510.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Vogt PK, Rommel C. PI3K: from the bench to the clinic and back. Curr Top Microbiol Immunol. 2011;347:1–19.
   Web of Science ®Google Scholar
• Westin JR. Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma. Clin Lymphoma Myeloma Leuk. 2014;14:335–342.
   PubMed Web of Science ®Google Scholar
• Abubaker J, Bavi P, Al-Haqawi W, et al. PIK3CA alterations in Middle Eastern ovarian cancers. Mol Cancer. 2009;8:1–12.
   PubMed Web of Science ®Google Scholar
• Jehan Z, Bavi P, Sultana M, et al. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. J Pathol. 2009;219:337–346.
   PubMed Web of Science ®Google Scholar
• Sun M, Hillmann P, Hofmann BT, et al. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha. Proc Natl Acad Sci USA. 2010;107:15547–15552.
   PubMed Web of Science ®Google Scholar
• Jaiswal BS, Janakiraman V, Kljavin NM, et al. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell. 2009;16:463–474.
   PubMed Web of Science ®Google Scholar
• Li X, Wu C, Chen N, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget 2016;7:33440–33450.
   PubMed Web of Science ®Google Scholar
• Massacesi C, Di Tomaso E, Urban P, et al. PI3K inhibitors as new cancer therapeutics: implications for clinical trial design. Onco Targets Ther. 2016;9:203–210.
   PubMed Web of Science ®Google Scholar
• Smith SM. New drugs for the treatment of non-Hodgkin lymphomas. Chin Clin Oncol. 2015;4:14.
   PubMedGoogle Scholar
• Workman P, Clarke PA, Raynaud FI, et al. Drugging the PI3 kinome: from chemical tools to drugs in the clinic. Cancer Res. 2010;70:2146–2157.
   PubMed Web of Science ®Google Scholar
• Gedaly R, Angulo P, Hundley J, et al. PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways. Anticancer Res. 2010;30:4951–4958.
   PubMed Web of Science ®Google Scholar
• Raynaud FI, Eccles S, Clarke PA, et al. Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res. 2007;67:5840–5850.
   PubMed Web of Science ®Google Scholar
• Fan QW, Knight ZA, Goldenberg DD, et al. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell. 2006;9:341–349.
   PubMed Web of Science ®Google Scholar
• Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends Cell Biol. 2013;23:620–633.
   PubMed Web of Science ®Google Scholar
• Segawa K, Nagata S. An apoptotic 'Eat Me' signal: phosphatidylserine exposure. Trends Cell Biol. 2015;25:639–650.
   PubMed Web of Science ®Google Scholar
• Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell. 2009;138:838–854.
   PubMed Web of Science ®Google Scholar
• Wu B, Zhou H, Hu L, et al. Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620. Tumor Biol. 2013;2:837–846.
   Web of Science ®Google Scholar
• Maurya AK, Vinayak M. Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention. Tumor Biol. 2015;36:8913–8924.
   PubMed Web of Science ®Google Scholar
• Maurya AK, Vinayak M. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol Biol Rep. 2015;42:1419–1429.
   PubMed Web of Science ®Google Scholar
• Pronsato L, Boland R, Milanesi L. Testosterone exerts antiapoptotic effects against H2O2 in C2C12 skeletal muscle cells through the apoptotic intrinsic pathway. J Endocrinol. 2012;212:371–381.
   PubMed Web of Science ®Google Scholar
• Pandey SK, Patel DK, Maurya AK, et al. Controlled release of drug and better bioavailability using poly(lactic-co-glycolic acid) nanoparticles. Int J Biol Macromol. 2016;89:99–110.
   PubMed Web of Science ®Google Scholar
• Maurya AK, Vinayak M. Quercetin regresses Dalton's lymphoma growth via suppression of PI3K/AKT signaling leading to upregulation of p53 and decrease in energy metabolism. Nutr Cancer. 2015;67:354–363.
   PubMed Web of Science ®Google Scholar
• Kanthasamy AG, Kitazawa M, Yang Y, et al. Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson's disease. Mol Brain. 2008;1:12.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang N, Hadden TJ, et al. Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 2011;1813:1978–1986.
   PubMed Web of Science ®Google Scholar
• Konopatskaya O, Poole AW. Protein kinase Calpha: disease regulator and therapeutic target. Trends Pharmacol Sci. 2010;31:8–14.
   PubMed Web of Science ®Google Scholar
• Lee SK, Shehzad A, Jung JC, et al. Protein kinase Cα protects against multidrug resistance in human colon cancer cells. Mol Cells. 2012;34:61–69.
   PubMed Web of Science ®Google Scholar
• Kang JH. Protein kinase C (PKC) isozymes and cancer. New J Sci. 2014;2014:231418.
   Google Scholar
• Mishra S, Vinayak M. Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice. Leuk Lymphoma. 2011;52:2155–2161.
   PubMed Web of Science ®Google Scholar
• Borutaite V, Brown GC. Caspases are reversibly inactivated by hydrogen peroxide. FEBS Lett. 2001;500:114–118.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mo X, Piper MG, et al. M-CSF induces monocyte survival by activating NF-κB p65 phosphorylation at Ser276 via protein kinase C. PLoS One. 2011;6:8081.
   Web of Science ®Google Scholar